Coroflex please
WebHe had a history of hypertension and CAD, a single-vessel disease treated in 2012 with a 2.5 × 28 mm paclitaxel-eluting stent (Coroflex ® Please; B. Braun Melsungen AG, Berlin, Germany) for the middle right coronary artery (mRCA). An electrocardiograph showed ST elevation in leads II, III, and aVF ( Figure 1A ). Figure 1 WebAug 27, 2012 · The Coroflex ® Please Registry was an international, prospective, multicenter registry enrolling patients with symptomatic ischemic heart disease. The …
Coroflex please
Did you know?
WebAs a subsidiary brand of the Coroplast Group, the WeWire business unit works worldwide on innovative solutions for the automotive industry. With around 8400 employees at currently 8 production sites and customer-oriented service centers, we … WebNational Center for Biotechnology Information
Webon the market is the the SeQuent™ Please device, a coronary balloon catheter that combines balloon angioplasty with local delivery of paclitaxel. In several small, but … WebCoroflex develops and produces for you at three locations! Read more. Related topics. Company ... Please call or write to us if you have any questions about Coroflex or the Coroplast Group or about our products and solutions. T +48 77 …
WebJun 18, 2008 · Patients will be randomized according to the type of drug eluting stent ( CoroflexTM Please vs. TaxusTM). Randomization will also be stratified per hospital for the presence of DM and the presence of long lesions (lesion length > 28mm) Patient Enrollment :915 patients enrolled at 13 centers in Korea. Patient Follow-Up WebBackground and Objectives: Various active stent coatings significantly reduce restenosis rates and target lesion revascularization compared to bare metal stents.Therefore, the …
WebMethods: The Coroflex(®) Please Registry was an international, prospective, multicenter registry enrolling patients with symptomatic ischemic heart disease. The primary endpoint was clinically driven target lesion revascularization (TLR) at 9 months. Secondary endpoints were technical success, in-hospital outcomes, definite stent thrombosis ...
WebOct 27, 2009 · B Braun has begun a 900-patient trial assessing the use of its paclitaxel-eluting Coroflex Please stent in percutaneous coronary intervention (PCI). The stent will be compared to Boston Scientific's Taxus Liberté, also coated with paclitaxel, in the non-inferiority study, called ECO-PLEASANT. The primary endpoint will be the rate of target … tel bankingWebMethods: The Coroflex® Please Registry was an international, prospective, multicenter registry enrolling patients with symptomatic ischemic heart disease. tel banrisulWebCoroflex China. 请选择品牌和国家 中國 请选择语言 取得联系 0 在关注列表中. 您的关注列表 您的关注列表仍然为空。请单击红色的加号（+）按钮，将产品添加到您的个人选择中。 ... tel banking postbankWebWe report on a young patient with ST-elevation myocardial infarction (STEMI) who presented to our emergency department arising from very late stent thrombosis (VLST) of a 2.5 × 28 mm paclitaxel-eluting stent (Coroflex ® Please) three years after its implantation. After the patient was treated with balloon dilation, intravascular ultrasound ... telbantWebAug 26, 2013 · Coroflex Please (B Braun, Melsungen, Germany) is a newly developed PES. We compared the clinical and angiographic efficacy of Coroflex Please with Taxus Liberte (Boston Scientific, Natick, MA) in a real-world practice. tel bantrabWebAug 18, 2010 · To establish the effectiveness and the safety of coronary stenting with the newly developed paclitaxel-eluting balloon expandable stent (CoroflexTM Please stent, B. Bran, Melsungen, Germany), compared to the conventional paclitaxel-eluting balloon expandable stent (TAXUS stent, Boston scientific) in the treatment of coronary stenosis. telbarWebOct 23, 2009 · Coroflex Please (B Braun, Melsungen, Germany) is a newly developed PES. We compared the clinical and angiographic efficacy of Coroflex Please with Taxus … tel bant